We found that tumors derived from Akirin2 knockdown cells grew more slowly, and the final tumor weight was markedly lower in the Akirin2 knockdown group than that in the negative control (sh-NC) group (Fig. 3a–c), which was consistent with the results in vitro. This evidence concerns the gene AKIRIN2 and neoplasm.